Clinical Trials Browser

Phase 1/2 × Extensive Stage Lung Small Cell Carcinoma × atezolizumab × Clear all

NCT05191797 2024-09-26

Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

3 enrolled 8 charts

Extensive Stage Lung Small Cell Carcinoma